BridgeMD
New treatment option for End-stage Liver Disease
Official title Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation
ClinicalTrials.gov ID: NCT07561138
What this study is testing
- What it's testing
- This study aims to evaluate the effects of a diet with even protein distribution plus exercise (Group A) versus a diet with skewed protein distribution plus exercise (Group B) versus standard dietary and physical activity advice (Group C) on nutritional status, body composition and functional status in patients awaiting liver transplantation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- End-stage liver disease, diagnosed by transient elastography (FibroScan) or imaging-based evaluation with compatible clinical picture
- Referred for liver transplantation and evaluated to have a high likelihood of being listed, according to primary hepatologist assessment, or already...
- No prior formal dietary advice
You likely can't join if
- Age \< 18 years old
- Estimated waiting time for liver transplantation \< 3 months
- Estimated life expectancy \< 3 months
- Chronic kidney disease requiring protein restriction
- Exercise contraindicated (e.g., active or recent variceal bleeding, severe grade of hepatic encephalopathy, refractory ascites, etc.)
- Unstable or severe psychiatric disorder
See the full eligibility criteria
- End-stage liver disease, diagnosed by transient elastography (FibroScan) or imaging-based evaluation with compatible clinical picture
- Referred for liver transplantation and evaluated to have a high likelihood of being listed, according to primary hepatologist assessment, or already listed for liver transplantation
- No prior formal dietary advice
- Age \< 18 years old
- Estimated waiting time for liver transplantation \< 3 months
- Estimated life expectancy \< 3 months
- Chronic kidney disease requiring protein restriction
- Exercise contraindicated (e.g., active or recent variceal bleeding, severe grade of hepatic encephalopathy, refractory ascites, etc.)
- Unstable or severe psychiatric disorder
- Pregnancy or lactation
- Inability to provide written informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Athens, Attica, Greece
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Athens, Attica, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.